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ABSTRACT
The aims of this study were to describe and compare the recent literature data 
of anthropometric and nutritional measurements in children with bronchial 
asthma from the researches published in the last 10 years. 46 studies from 
the year 2003 to 2014 were reviewed and analyzed along with the informa-
tion published before. The measurements reviewed include body height, body 
weight, body mass index and body composition.
The severity and duration of bronchial asthma, along with the inhaled 
corticosteroid treatment, negatively correlate with the height of the children. 
Also, the fat free mass of the body is decreased and fat mass is increased. Due 
to more robust body build and the body mass index in children with bronchial 
asthma is usually increased if compared to healthy children. An increased 
body mass index in these children reduces the effectiveness of the treatment. 
Increased body mass index can also be a predictor for the risk for developing 
late onset bronchial asthma in girls.
Keywords: bronchial asthma, body mass index, body height, body weight, body 
composition, inhaled corticosteroids
INTRODUCTION
Bronchial asthma (BA) is a chronic lung disease, affecting up to 11% of the 
world population [25]. In Latvia it affects 2–5% of population (according to 
Latvia Alergologists Association data, 2010). The prevalence of BA in children 
in Latvia is 9.5%, and 35% of the children affected by the disease is under the 
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age of 2 years (according to Children Clinical University Hospital data, Riga, 
2010).
According to different studies from the 1970s to the 1990s, bronchial 
asthma is one of the factors impacting the growth and development of chil-
dren. Although a considerable number of studies, using different study designs, 
indicate that the risk of asthma development, the topic remains controversial 
because of potential methodological limitations inherent in many of these 
studies.
The aim of the study was to collect and analyze the recent literature data 
of anthropometric and nutritional measurements in children with bronchial 
asthma from the researches published from theb year 2003 to 2014.
MATERIAL AND METHODS
Published papers were searched using the Medline/Pubmed database. Further-
more, references in the selected publications were checked for relevant publica-
tions not included in the Medline/Pubmed search.
RESULTS
Bronchial asthma, body height and body weight. It has been established since 
the 1980s that the children with BA tend to be lower in height than healthy 
children [35]. In the study carried out by Umlawska et al., 2013, which included 
261 children with bronchial asthma, it was concluded that about 5% of the 
children with BA were very short in stature: their height was under the 5th 
percentile of the growth charts [48].
The height of the child with BA is impacted by several factors: the age at 
diagnosis, duration and the severity of the disease, recurrent respiratory infec-
tions, chest deformity, muscle shortening and postural adaptations, hypox-
emia, the impaired pulmonary function, enhanced metabolic demands of the 
increased work of breathing and allergic processes and corticosteroid treatment 
[19, 26, 48].
It has also been observed that the children with untreated or poorly treated 
asthma experience late onset puberty and the delay in pubertal growth spurt 
by approximately 1.3 years [13, 19].
The relative weight of the children with BA, however, may not be influenced 
by the disease. In the mentioned study carried out by Umlawska et al., 2013, 
there was no significant correlation between the severity or duration of the 
disease and relative body weight. However, the children with BA have a differ-
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ent body composition, compared to their healthy peers [48] (see the section 
“Bronchial asthma and body composition”). 
Bronchial asthma and the body mass index. The body mass index (BMI) 
is a nutritional measurement, defined as the individual’s body mass divided 
by the square of their height – with the value in units of kg/m2 [4]. In chil-
dren, the BMI number is plotted on the BMI-for-age growth charts for girls or 
boys to obtain a percentile ranking. The BMI below the 5th percentile means 
underweight; the BMI between the 5th up to the 85th percentile means normal 
weight; the BMI between the 85th and the 95th percentile means overweight, 
and BMI above the 95th percentile means obesity [5].
It has been established since the 1980s that BA, as a chronic disease, has an 
impact on the BMI [32]. Still, there is no united opinion if BA can be respon-
sible to increased or decreased BMI in both boys and girls.
A research carried out by Scepanovic et al., 2013, states that a significant 
number of children with BA are both overweight and underweight if com-
pared for the healthy children. Considerable differences between the sick and 
healthy children occur in different age groups: boys differ at ages 8–9 and 
13–15, whereas girls differ at ages 6–7 and 10–12 [41].
The results in different studies, however, show that the children with BA 
have an increased BMI, if compared to healthy children, and these differences 
can be found in all age groups. Ahmadiafshar et al., 2013, and Umlawska et 
al., 2013, state that there is no significant correlation between the BMI and the 
severity and treatment of the disease [1, 48]. Another research by Szroniak et 
al., 2008, however, states that the severity of asthma correlates with the higher 
BMI [46].
The increased BMI in these children has an impact on the disease as well 
[15, 24, 28]. As stated in a research by Holguin et al, 2011, obese children 
with BA are more likely to have continuous cough, sputum production, chest 
tightness, wheeze, dyspnea, nocturnal symptoms, and a reduced quality of life 
if compared to the children with normal BMI or overweight. Similarly, they 
are more likely to have exacerbations, requiring oral steroids and the use of 
healthcare resources, including hospital visits, admissions in the Intensive care 
unit, and mechanical ventilation [24]. Obese and overweight children with BA 
tend to have reduced lung volume ratios (functional residual capacity/total 
lung capacity (TLC) and residual volume/TLC) [28]. Furthermore, the obese 
adolescents with BA have a higher prevalence of the metabolic syndrome than 
the obese adolescents without BA, more significantly in boys [11].
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Bronchial asthma and body composition. The body composition is evalu-
ated by distinguishing the fat mass (FM) and the fat free mass (FFM). Skinfold 
thickness measurements are widely used to assess the size of specific subcu-
taneous fat depots. Measuring waist circumference is a simple way to deter-
mine the central fatness [53]. Waist-to-height ratio can be used as a proxy 
measure of visceral adipose [40]. Body composition can be estimated using the 
upper arm muscle area (UMA), which can be calculated using the following 
formula: (arm circumference − (π × triceps skinfold thickness))2/4π. The total 
upper arm area (TUA) can be calculated by the following formula: (upper arm 
circumference)2/4π. The upper arm fat area then can be calculated using the 
formula: TUA-UMA [17].
The body fat percentage might be calculated, using the biolelectrical imped-
ance [6] or estimated from BMI, using the following formula: (1.51 × BMI) – 
(0.70 × age) – (3.6 × sex) + 1.4, where sex is 1 for boys and 0 for girls [12].
In a research of Antonio et al., 2003, it was concluded that the triceps skin-
fold in the girls with BA was significantly larger than in healthy girls [3]. As 
shown later in a study by Umlawska et al., 2013, between the children with 
BA, the upper arm circumference, the body fat content and the muscle mass 
were significantly higher in girls than boys; therefore, the body build was more 
robust [48].
It was published in 2009 by Musaad et al. that central obesity, determined 
by the waist circumference, is correlated with BA, the severity of the disease 
and the lower lung function [31]. Later several researches published from 2011 
to 2014 state that wheezing and BA correlate with a larger waist circumference 
and a smaller waist-to height ratio [33, 43, 49].
A detailed research by Guibas et al., 2013, states that the measurements 
correlating with bronchial asthma differ depending on the age groups [21]. 
In the children aged 2–5 years, BA positively correlated with the waist-to-hip 
circumference; biceps, triceps, subscapular and suprailiac skinfold thickness; 
and skinfold-derived percentage fat mass but not BMI or BMI-defined over-
weight and obesity. In the children aged 9–13 years, BA was positively associ-
ated with the waist circumference, the waist-to-height ratio, skinfold thickness, 
skinfold-derived percentage fat mass, the BMI, the BMI-defined overweight or 
obesity.
Yiallouros et al., 2013, researched the body fat percentage correlation with 
BA. It was concluded that the body fat percentage was significantly higher in 
the children with BA in the age of 7–8 years and 16–17 years, but not in the age 
groups in between [56].
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Bronchial asthma treatment with inhaled corticosteroids and its impact on 
the anthropometric and nutritional measurements. The Global Initiative for 
Asthma – GINA 2010 guidelines places emphasis on the use of inhaled cor-
ticosteroids (ICS) for asthma because they have reduced asthma mortality 
and morbidity; they reduce asthma symptoms, improve the lung function and 
reduce the number of exacerbations. However, one of the side effects of the ICS 
is effecting the growth. As published already in the year 200 by Davis et al., the 
ICS inhibit mediators of the growth axis in children, like the secretion and the 
action of the growth hormone, the action of insulin-like growth factors, colla-
gen synthesis and adrenal androgen production. The effects of ICS depend on 
the type of the drug, the dose, and the amount of drug that is absorbed [9]. A 
study by Sim et al., 2003, suggested that high-dose ICS can induce adrenal sup-
pression in children with BA [45]. In 2004 Mohn et al., published a research, 
suggestng that also low dose ICS treatments are associated with the adrenal 
axis suppression [30].
Studies show that the children with BA, who receive long-term inhaled cor-
ticosteroid therapy, have height deficits 1–2 years after the treatment initiation 
that persist into adulthood [18]. The height deviation scores negatively cor-
relate with the severity of asthma and a larger ICS dose [36, 39]. Also, younger, 
prepubertal children, appear more sensitive to the growth suppressive effects 
of ICS. It has also been established that using of the ICS also results in delayed 
puberty [13, 14].
The ICS treatment seems to influence the bone age of the short bones. A 
research by Wang et al., 2012, measured radius, ulna, carpal bones and short 
finger bones for the bone age of the children before and one year after an inha-
led glucocorticosteroid treatment [52]. It was concluded that the treatment 
with ICS for one year may suppress the level of carpal bone age, but the level 
of radius, ulna and short finger bones` bone age are not affected during one 
year of the ICS treatment [36]. However, the long-term treatment with inhaled 
corticosteroid therapy is safer than the frequent doses of oral corticosteroids, 
for its side effect on disrupting the normal bone mineralization [18].
The question, if the ICS treatment for BA in children makes them shorter 
adults, has been urgent. The latest results, published by Raissy et al., 2013, 
show growth retardation, not suppression, in adult heights of the children who 
were treated with ICS [37]. The effect of the ICS is sustained and not cumula-
tive and can be reduced with the appropriate selection of ICS with the highest 
therapeutic index on the lowest effective dose. The reduction in the final adult 
height is unlikely to exceed 1.2 cm and the ICS effect on growth, is outweighed 
by the benefits of the ICS treatment [13, 37].
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The body composition and BMI might also be affected by the ICS treat-
ment. The ICS may affect lipid metabolism and increase the adipose mass, as 
published already in 2001 by Aldamiz-Echevarria et al, whose research results 
showed that the boys with BA, who received ICS treatment for at least 12 
months, had a lower fat free mass compared to those ICS free [2].
Several studies show that the BMI in children with BA, receiving ICS treat-
ment, is generally higher than those who are ICS free [44, 50]. However, a study 
carried out by Wang et al., 2012, showed that during one year of ICS treatment 
in a medium dosage the BMI was not affected [52].
As the increased BMI has an influence on the disease, it also alters the 
therapeutic effects of the ICS. A research carried out by Ye Huang et al., 2013, 
evaluated the BMI and the lung function of the children with BA who received 
ICS treatment for one year [55]. It was concluded that the therapeutic effects 
of ICS are reduced in obese children.
Increased body mass index as a risk factor for bronchial asthma. In 2004 a 
large study by To et al. was published including 11,199 Canadian children, 
who had an increased BMI and whose mothers had BA [47]. The results of this 
study showed that and the increased BMI is not a risk factor for developing BA 
in children.
But the latest studies show different results. Several researches among the 
populations of the USA, Puerto Rico, Australia and Canada, that include 600–
39 000 children in several age groups, state that and the increased BMI (both 
overweight and obesity) is a risk factor for developing BA in girls. [7, 16, 20, 
29, 54].
Also the current research carried out by Hawlader et al., 2014, in Bangla-
desh, including 912 children, shows that also underweight and malnutrition 
constitute a risk factor for wheezing in both boys and girls [23].
There are few studies that prove the correlation between the increased BMI 
and the risk of BA in boys. A study by Porter et al., 2012, states that the boys 
with BMI above the 85th percentile in the age of 8–9 years develop BA until 
the age of 18–20 years 7.4% more times often, compared to the boys with BMI 
below the 85th percentile at the age of 8–9 years [34]. Similarly a research by 
Magnusson et al., 2012, states that both boys and girls with and increased BMI 
at the age of 4 years do not have an increased risk of developing BA, compared 
to the children with normal BMI [27]. However, an increased BMI at the age 
of 7 and more years correlates with an increased risk of developing BA for both 
sexes.
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Different researches in the past couple of years show that BMI alone is not 
enough to establish the risk of developing BA. A research by Wang R et al., 
2013, analyzes not only the BMI, but also the percent body fat (PBF) and the 
percent truncal fat (PTF) [51]. It was revealed that increased PBF and PTF 
was associated with the reduced forced expiratory volume in the first second 
(FEV1) and forced vital capacity (FVC), but only in boys. In girls, the increased 
PBF and PTF correlated with the risk of developing BA. Another research by 
Chen et al., 2014, states that central obesity (increased abdominal circumfer-
ence) is the most accurate predictor of the risk of developing BA in both boys 
and girls [8].
DISCUSSION
Two phenotypes of asthma are known in the overweight and obese: one group 
with the early onset BA, which is complicated by overweight or obesity, and 
another group with the late onset BA, which is consequent to obesity [42]. 
The majority of children with the early onset asthma are most likely to experi-
ence their first episode of BA until the age of 6 years. The late onset asthma, 
however, may be diagnosed variably from the age of 12 years to more than 65 
years [10].
The children with the early onset asthma, as well as the children with the 
late onset asthma, diagnosed in early adulthood, will experience the changes in 
growth velocity and body composition. In the children with the late onset BA, 
however, the body composition and therefore BMI might already be altered 
and can be a significant risk factor for the disease to develop.
The children with the early onset BA are predisposed to a BMI increase, 
both overweight and obesity, due to the reduction in height and the increasing 
body fat amount and more robust body-build.
The inflammatory mediators that are responsible for the immune process 
of BA are cytokines, chemokines, growth factors, obesity related cytokines (or 
adipokines), immunoglobulins and histamine. Overweight and obesity lead 
to changes in immune cell function and changes in immunometabolism [22, 
38]. This is a relatively new field of research, and future studies may give a 
better understanding of the mechanism of the increase of the body fat in the 
children with BA. Also, as stated in 1992 by Zeitlin et al., the basal metabolic 
rate is higher in the children with BA than in healthy children because of the 
increased difficulty in breathing [57].
The height, the BMI and the body composition in children with both the 
early and the late onset BA are affected by the disease mechanisms and the 
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severity of the disease, as well as the ICS treatment. The growth delay can be 
observed in the children who have poor asthma control, as well as it can nega-
tively correlate with the higher doses of the ICS received for treatment. The 
ICS effect on growth, however, is less significant compared to the benefits of 
the ICS treatment.
It is unclear whether higher BMI is associated with the duration and the 
severity of the disease. The ICS effect on the BMI and the body composition 
is also debatable. It is more likely for the ICS adverse effects to appear after a 
systematic use in a longer period of time and depend on the dosage and the 
type of the corticosteroid.
The height, weight and the BMI should be regularly controlled in the chil-
dren with BA; measuring of skinfold thickness, the waist circumference and the 
waist-to-height ratio may also be beneficial. The frequency of taking measures, 
however, is not determined. If a child’s BMI is evaluated at least twice a year, it 
may benefit in the early determining of the risk of overweight and obesity, and 
perhaps a different diet or exercise regimen can be applied. Otherwise these 
children may become less responsive to the ICS treatment and will be predis-
posed to a more severe presentation of the BA due to overweight and obesity.
It is still unclear whether and which measurements are the most effective pre-
dictors for the risk of developing the late onset BA in both sexes. The measure-
ments and the correlating risk factors depend on the sex and the age of the child. 
It has been established that increased BMI, both overweight and obesity, can be 
a predicting risk factor for developing BA in girls, most effectively from the age 
of 7 years. A decreased BMI in small children can be a risk factor of wheezing. 
More studies are necessary for establishing the significance in PBF and PTF as 
well as the central obesity in predicting the risk of BA in boys and girls.
CONCLUSIONS
This information, which has been generated by different studies, offers a pos-
sibility for comparing the impact of BA on the anthropometric and nutritional 
development of children. The severity and duration of BA, along with the ICS 
treatment, negatively correlate with the height of the children. The relative 
body weight may not be influenced by bronchial asthma; however, the FFM is 
decreased and the FM is increased. The BMI in children with BA, compared 
to healthy children, can be increased due to a more robust body build. An 
increased BMI in the children with BA reduces the effectiveness of the ICS 
treatment. In girls, an increased BMI can also be a predictor for the risk of 
developing the late onset BA.
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ABBREVIATIONS
Bronchial asthma (BA); Body mass index (BMI); Forced expiratory volume in 
the first second (FEV1); Fat free mass (FFM); Fat mass (FM); Forced vital 
capacity (FVC); Inhaled corticosteroids (ICS); Percent body fat (PBF); Per-
cent truncal fat (PTF); Total lung capacity (TLC); Total upper arm area (TUA); 
Upper arm muscle area (UMA)
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